We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




MEDICA 2022 to Take a Look at New Digital Reality and Revolutionary Technologies

By LabMedica International staff writers
Posted on 10 Oct 2022
Print article
Image: For start-ups, MEDICA is the gateway to the world (Photo courtesy of Pexels)
Image: For start-ups, MEDICA is the gateway to the world (Photo courtesy of Pexels)

As one of the world's leading medical trade fairs, MEDICA (Düsseldorf, Germany) in Düsseldorf presents innovations every year for the entire healthcare workflow, for clinical and outpatients. Among the over 4,200 companies at MEDICA 2022 (duration: 14 – 17 November) there will again be several hundred start-ups. This event, which is one of the most international trade fairs (more than 70% of all visitors hail from abroad, and about 150 nations overall are represented), is a gateway to the world for them, through which they can make contacts across all continents.

One example is the MEDICA CONNECTED HEALTHCARE FORUM (in Hall 12), a special platform for young entrepreneurs. The most important issues of the four-day-program for the year 2022 are: Connected medical things, AI & big data, robotics, the health metaverse, the future of hospitals and care centers, health monitoring and diagnostics, mobile health, digital therapeutics, mental health, and more. About a hundred chosen start-ups and scale-ups present themselves on the forum stage during the MEDICA DISRUPT Sessions. The finale of the 11th MEDICA Start-Up COMPETITION and the "14th Healthcare Innovation World Cup" are highlights of the program.

The 11th MEDICA Start-Up COMPETITION is on the lookout for innovative healthcare industry solutions, from health apps and new tools for gathering and AI-supported analysis of health data, to robotic assistance systems and new approaches in diagnostics. Until mid-September, hundreds of innovators had already registered their participation in the finale of the competition during MEDICA 2022. The 12 best finalists, chosen by a professional jury, will now pitch on 15 November at 1 p.m. to win the grand prize. A day before, on 14 November at 1 p.m., the finale for the "14th Healthcare Innovation World Cup" will start. There, another 12 chosen finalists will pitch to win with their solutions for the "Internet of Medical Things" (IoMT). The span of developments reaches from interconnected medical technological devices, wearable technologies, digital biomarkers and intelligent plasters up to smart implants.

In addition, the metaverse is going to be one of the important topics at the MEDICA CONNECTED HEALTHCARE FORUM. The new buzzword hints at a novel digital reality that focuses on technologies like virtual reality (VR) and augmented reality (AR), the possibilities of processing big data in real time by artificial intelligence, and digital twins. This could lead to revolutionary changes in health care, both for monitoring health and treatments. This trend provides the focus for the content of a symposium, starting on Wednesday, 16 November, at 12 p.m. There, Eva Garcia Ramos, CEO and co-founder of WIVI Vision, will speak. The start-up concentrates mostly on children and adolescents. The products (for example with the capacity for 3D visualization) aim to improve health care with a view to evaluating and treating problems with visual function.

Khora, a Danish start-up, will also be present on stage at the MEDICA CONNECTED HEALTHCARE FORUM. The start-up has worked with the Rigshospitalet to create, for example, an AR universe aimed at children and adolescents from ages ten to fourteen, who have to spend considerable time in hospital with cancer or leukemia. It is supposed to make daily life easier for them. Khora created "Snail Battle", which allows persons affected to use plants to fight against evil monster snails. During the MEDICA CONNECTED HEALTHCARE FORUM, CEO Simon Lajboschitz will also explain, how VR can help patients with schizophrenia affected by auditory hallucinations. The metaverse can offer opportunities in many other areas, ranging from applications for attention deficit disorder over the development and testing of medical devices on virtual patients to simulation scenarios. These will be the focus of talks on Wednesday, 16 November.

Thericon and KuartisMED are among the companies participating in the MEDICA START-UP PARK. The shared booth (also located in Hall 12) has established itself over the years as a central meeting point for business and networking with the young founders' scene, and this year counts around 40 participants. German start-up Thericon see themselves as the first company to bring imaging compiled from several different sources into the operating theatre as a visual aid. Visual representations of hitherto invisible tissue properties are presented together with standard colored images on a single monitor. This diagnostic information and their intuitive display aims to make faster and more precise surgical results possible. The company’s MEDICA START-UP PARK presentation explains how it works in detail. Meanwhile, Turkish company KuartisMED concentrates on innovative solutions for the well-being of newborns. As children born before the 34th week of gestation lack sufficient coordination of the sucking and swallowing reflexes, they depend on feeding tubes for nutrition. The non-invasive medical device by KuartisMED aims to help with evaluating the maturity of these reflexes in the future. These aforementioned examples show that for those interested in innovations in the health sector, a visit to MEDICA 2022, and especially the novelties presented by the various start-ups, is a must.

Related Links:
MEDICA

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more

Pathology

view channel
Image: The new method could reduce undiagnosed cancer cases in less-developed regions (Photo courtesy of 123RF)

New Method Offers Sustainable Approach to Universal Metabolic Cancer Diagnosis

Globally, more than one billion people suffer from a high rate of missed disease diagnosis, highlighting the urgent need for more precise and affordable diagnostic tools. Such tools are especially crucial... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.